SYRS Syros Pharmaceuticals Stock Quotes

Syros Pharmaceuticals (SYRS) is developing a gene management system that enables the modification of cells for cardiac pathologies and oncohematology. Research stability is ensured through diversified component delivery and long-term agreements with laboratories. The visualization of market value on GURU.Markets at the value of 0.12 is supplemented by data on the outsourcing of drug production to third-party US cGMP plants, which minimizes technical disruptions.

Price Performance Chart: Syros Pharmaceuticals (SYRS) for 07/04/2022 - 03/29/2025

Syros Pharmaceuticals, Inc (SYRS) - metric breakdowns and financial figures

- stock value and consensus price forecast:

Price Chart Syros Pharmaceuticals Inc.|SYRS - Analyst Median Target

- market capitalization data:

Market Valuation Syros Pharmaceuticals Inc.|SYRS - Total Enterprise Value

- issuer book value statistics:

Net Assets per Single Share Syros Pharmaceuticals|SYRS - Accounting Value of Company|Market Value to Book Value Ratio syros.com|SYRS - Company Total Asset Base

- debt level and financial liquidity data:

- company profitability and valuation multiples indicators:

SYRS - Company Net Income|Expected Profit Syros Pharmaceuticals|SYRS - Company Value to Net Income|Future Price to Earnings syros.com|SYRS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Syros Pharmaceuticals, Inc.|SYRS - Operating income before deduction of amortization|Net earnings per share for the last 12 months Syros Pharmaceuticals|SYRS - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months syros.com|SYRS - Earnings per share trend in current year|Earnings growth forecast for next year Syros Pharmaceuticals

- sales volume and revenue information:

SYRS - Company Sales Revenue|Projected Sales Volume syros.com|SYRS - P/S Multiple|Price-to-Projected Revenue Ratio Syros Pharmaceuticals

Summary company analytics:syros.com

This indicator serves as a tool for benchmarking market quotes against fundamental triggers, allowing for an assessment of investor reaction to technological breakthroughs and financial results. For Syros Pharmaceuticals (SYRS), the chart's price action reflects the market's revaluation of the potential of cancer cell reprogramming methods, where each price impulse confirms either success in gene expression or rising expectations for future clinical reports.

Analysis of competing companies